GRANULES.NSE Granules India Ltd.

Granules India’s net profit tanked 62.4 percent YoY to Rs 47.9 crore.

This is Granules India’s fourth FDA audit since March with zero observations.

This product will be launched through Granules Consumer Health (GCH) division.

The Nifty is likely to continue its march upwards amid consolidation with hurdle at 19,500-19,600 levels, whereas the near term support is expected to be 19,300-19,200 levels, followed by crucial support at 19,000, experts said

It is advisable to secure profits at higher levels and avoid complacency until the indicators exit the overbought territory.

The share touched a 52-week high of Rs 381.25 and a 52-week low of Rs 267.85 on 04 November, 2022 and 29 March, 2023, respectively.